in this issue
Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients
Pharma/fine chemicals roundup—18 March 2014
March 18, 2014 | Deepti Ramesh
DSM and JLL create $2-billion pharma services firm DPx DSM and private equity firm JLL Partners (New York) say that they have created DPx Holdings, a new privately held company, by combining DSM Pharmaceutical Products (Parsippany, NJ), the custom manufacturing and technology business of DSM, with Patheon (Toronto), a portfolio company of JLL. DSM and JLL first announced plans to create the new company in November 2013. DPx, which is a leading global contract development and manufacturing organization (CDMO) for the pharmaceutical industry with anticipated annual...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee